{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:57:18Z","timestamp":1791593838827,"version":"4.3.4"},"reference-count":0,"publisher":"American Society for Clinical Investigation","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Invest."],"published-print":{"date-parts":[[1994,11,1]]},"DOI":"10.1172\/jci117520","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T14:47:26Z","timestamp":1204296446000},"page":"1729-1735","source":"Crossref","is-referenced-by-count":327,"title":["High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments."],"prefix":"10.1172","volume":"94","author":[{"given":"M","family":"Basta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Dalakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jci.org\/articles\/view\/117520\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:49:53Z","timestamp":1691081393000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jci.org\/articles\/view\/117520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,11,1]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1994,11,1]]}},"URL":"https:\/\/doi.org\/10.1172\/jci117520","relation":{},"ISSN":["0021-9738"],"issn-type":[{"value":"0021-9738","type":"print"}],"subject":[],"published":{"date-parts":[[1994,11,1]]}}}